Page last updated: 2024-11-13

sodium bromate

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

sodium bromate : An inorganic sodium salt having bromate as the counterion. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID23668195
CHEMBL ID1348453
CHEBI ID75229
MeSH IDM0168208

Synonyms (41)

Synonym
bromate de sodium
7789-38-0
sodium bromate
bromic acid, sodium salt
AKOS015833691
NCGC00090778-02
NCGC00090778-01
un1494
bromate de sodium [french]
sodium bromate(dot)
hsdb 2185
einecs 232-160-4
nsc 77383
dyetone
sodium bromate, >=99%
sodium bromate, puriss. p.a., >=99.5% (rt)
ccris 9265
unii-u54jk6453o
bromic acid, sodium salt (1:1)
u54jk6453o ,
sodium bromate [un1494] [oxidizer]
ec 232-160-4
cas-7789-38-0
tox21_202534
dtxcid603837
NCGC00260083-01
dtxsid9023837 ,
CHEBI:75229 ,
nabro3
BR1198
sodium bromate [hsdb]
sodium bromate [inci]
sodium bromate [mi]
XUXNAKZDHHEHPC-UHFFFAOYSA-M
CHEMBL1348453
mfcd00003476
FT-0699768
sodium bromate, p.a., 99.5%
Q414567
na br o3
sodium;bromate

Research Excerpts

Overview

Sodium bromate is a strong oxidant used as a neutralizing solution in hair permanents. Bromate intoxication can cause irreversible severe-to-profound sensorineural hearing loss.

ExcerptReferenceRelevance
"Sodium bromate is a strong oxidant, and bromate intoxication can cause irreversible severe-to-profound sensorineural hearing loss. "( Hearing recovery from deafness caused by bromate intoxication.
Katori, Y; Koyama, A; Suzuki, J; Takanashi, Y, 2018
)
1.92
"Sodium bromate is a strong oxidant used as a neutralizing solution in hair permanents, as well as an auxiliary agent in printing and dyeing. "( Acute kidney injury due to sodium bromate intoxication: a report of two cases.
Do, JY; Jang, KA; Kim, SM; Park, JW; Ryu, DH; Yoon, KW, 2011
)
2.11

Toxicity

ExcerptReferenceRelevance
" One of the important issues considering ballast water treatment is to determine whether treated ballast water, once discharged, is safe to the aquatic environment."( Acute and chronic toxicity of selected disinfection byproducts to Daphnia magna, Cyprinodon variegatus, and Isochrysis galbana.
Burton, D; Fisher, D; Friedel, E; Yonkos, L; Ziegler, G, 2014
)
0.4
" Several DBPs have been implicated in a variety of toxic effects, mainly carcinogenic and genotoxic effects."( Developmental effects and genotoxicity of 10 water disinfection by-products in zebrafish.
Gómez-Catalán, J; Gonzalez-Linares, J; Llobet, JM; Piqué, E; Teixidó, E, 2015
)
0.42
"Acute toxic effects of potassium bromate, sodium bromate and potassium bromide on luminescent bacteria, water flea, green alga and zebrafish were studied using standard toxic testing methods."( [Acute Toxic Effects of Bromate on Aquatic Organisms].
Cui, FY; Liu, DM; Wang, ZW; Zhang, WJ, 2016
)
0.7

Dosage Studied

ExcerptRelevanceReference
" Survival of dosed groups was similar to that of vehicle control groups at 26 and 39 weeks."( Toxicology studies of sodium bromate (CAS No. 7789-38-0) in genetically modified (FVB Tg.AC Hemizygous) mice (dermal and drinking water studies) and carcinogenicity studies of sodium bromate in genetically modified [B6.129-Trp53tm1Brd (N5) haploinsufficie
, 2007
)
0.65
"AC hemizygous mice dosed dermally with sodium bromate."( Toxicology studies of sodium bromate (CAS No. 7789-38-0) in genetically modified (FVB Tg.AC Hemizygous) mice (dermal and drinking water studies) and carcinogenicity studies of sodium bromate in genetically modified [B6.129-Trp53tm1Brd (N5) haploinsufficie
, 2007
)
0.92
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (2)

RoleDescription
oxidising agentA substance that removes electrons from another reactant in a redox reaction.
nephrotoxinA poison that interferes with the function of the kidneys.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (2)

ClassDescription
bromate saltAny salt that has chlorate, [BrO3](-), as the anionic component.
inorganic sodium salt
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (6)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Chain A, CruzipainTrypanosoma cruziPotency22.38720.002014.677939.8107AID1478
GLI family zinc finger 3Homo sapiens (human)Potency13.28980.000714.592883.7951AID1259369
AR proteinHomo sapiens (human)Potency6.71860.000221.22318,912.5098AID743035
aldehyde dehydrogenase 1 family, member A1Homo sapiens (human)Potency30.30010.011212.4002100.0000AID1030
mitogen-activated protein kinase 1Homo sapiens (human)Potency100.00000.039816.784239.8107AID995
Nuclear receptor ROR-gammaHomo sapiens (human)Potency54.23470.026622.448266.8242AID651802
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (13)

Processvia Protein(s)Taxonomy
negative regulation of transcription by RNA polymerase IINuclear receptor ROR-gammaHomo sapiens (human)
xenobiotic metabolic processNuclear receptor ROR-gammaHomo sapiens (human)
regulation of glucose metabolic processNuclear receptor ROR-gammaHomo sapiens (human)
regulation of steroid metabolic processNuclear receptor ROR-gammaHomo sapiens (human)
intracellular receptor signaling pathwayNuclear receptor ROR-gammaHomo sapiens (human)
circadian regulation of gene expressionNuclear receptor ROR-gammaHomo sapiens (human)
cellular response to sterolNuclear receptor ROR-gammaHomo sapiens (human)
positive regulation of circadian rhythmNuclear receptor ROR-gammaHomo sapiens (human)
regulation of fat cell differentiationNuclear receptor ROR-gammaHomo sapiens (human)
positive regulation of DNA-templated transcriptionNuclear receptor ROR-gammaHomo sapiens (human)
adipose tissue developmentNuclear receptor ROR-gammaHomo sapiens (human)
T-helper 17 cell differentiationNuclear receptor ROR-gammaHomo sapiens (human)
regulation of transcription by RNA polymerase IINuclear receptor ROR-gammaHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (10)

Processvia Protein(s)Taxonomy
RNA polymerase II cis-regulatory region sequence-specific DNA bindingNuclear receptor ROR-gammaHomo sapiens (human)
DNA-binding transcription factor activity, RNA polymerase II-specificNuclear receptor ROR-gammaHomo sapiens (human)
DNA-binding transcription repressor activity, RNA polymerase II-specificNuclear receptor ROR-gammaHomo sapiens (human)
DNA-binding transcription factor activityNuclear receptor ROR-gammaHomo sapiens (human)
protein bindingNuclear receptor ROR-gammaHomo sapiens (human)
oxysterol bindingNuclear receptor ROR-gammaHomo sapiens (human)
zinc ion bindingNuclear receptor ROR-gammaHomo sapiens (human)
ligand-activated transcription factor activityNuclear receptor ROR-gammaHomo sapiens (human)
sequence-specific double-stranded DNA bindingNuclear receptor ROR-gammaHomo sapiens (human)
nuclear receptor activityNuclear receptor ROR-gammaHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (4)

Processvia Protein(s)Taxonomy
nucleusNuclear receptor ROR-gammaHomo sapiens (human)
nucleoplasmNuclear receptor ROR-gammaHomo sapiens (human)
nuclear bodyNuclear receptor ROR-gammaHomo sapiens (human)
chromatinNuclear receptor ROR-gammaHomo sapiens (human)
nucleusNuclear receptor ROR-gammaHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Research

Studies (39)

TimeframeStudies, This Drug (%)All Drugs %
pre-19902 (5.13)18.7374
1990's8 (20.51)18.2507
2000's11 (28.21)29.6817
2010's18 (46.15)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 61.42

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be very strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index61.42 (24.57)
Research Supply Index3.74 (2.92)
Research Growth Index5.06 (4.65)
Search Engine Demand Index97.96 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (61.42)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (2.44%)6.00%
Case Studies9 (21.95%)4.05%
Observational0 (0.00%)0.25%
Other31 (75.61%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]